Research Article Volume 8 Issue 2
PRM department, University Hospital of Rabat, Mohammed V University, Morocco
Correspondence: Sara Skalli, PRM department, University Hospital of Rabat, Mohammed V University, Faculty of medicine and Pharmacy of Rabat, Morocco, Tel +212 6 61 50 42 51
Received: August 06, 2023 | Published: August 23, 2023
Citation: Skalli S, Karkouri S. Robotic training in the management of adhesive capsulitis: a randomized controlled trial protocol. Int Phys Med Rehab J. 2023;8(2):167-171. DOI: 10.15406/ipmrj.2023.08.00354
Background: Adhesive capsulitis (AC) is characterized by pain and limitation of active and passive range of motion. Its development leads to functional limitation and cortical reorganization. There is no consensus regarding the treatment of this condition as the pathophysiology is not yet clearly understood. Rehabilitation focuses on functional tasks during physical therapy sessions to improve patient autonomy. The purpose of this study is to evaluate the efficacy of robotic training compared to conventional rehabilitation in patients with AC.
Materials and methods: It’s a single-blind, randomized, controlled trial conducted at the Department of Physical Medicine and Rehabilitation, Rabat University Hospital, Morocco. This prospective analytical study compares robotic training with the Armeo® Spring device combined with passive continuous mobilization to conventional physical therapy in patients with AC. Participants will be evaluated prior to randomization and followed up at 3 weeks, 6 weeks, 3 months, 6 months, and 12 months. The main outcome is the Shoulder Pain and Disability Index (SPADI). Secondary outcomes are: pain, active and passive range of motion, SF-36 index.
Adhesive capsulitis (AC) is a condition characterized by pain and three-dimensional limitation of active and passive range of motion (ROM) of the shoulder,1 leading to underuse of the affected extremity and, in some cases, Kinesiophobia – fear of moving.2 This limits the function of the affected limb, impairs activities of daily living, and limits social and professional participation. The result is a frozen shoulder and poor quality of life.3 The prevalence of AC in the general population is 2% to 5%, especially in women aged 40 to 60 years.4 The goals of treatment are to reduce pain and increase shoulder range of motion to improve shoulder function. Treatment protocols include pharmacological and non-pharmacological modalities.5 Medications involve analgesics, anti-inflammatory drugs, intra-articular steroid injections, or hydro dilation (dilation of the shoulder joint by injecting saline or contrast media under general or local anesthesia).6 Non-pharmacological approaches include functional rehabilitation. This is the core of treatment and can be continued long-term through home self-program:7,8
To propose an instrumental rehabilitation for AC patients based on the above measures, we conduct this randomized controlled trial to evaluate the effectiveness of robotic training compared with conventional rehabilitation for AC patients.
Study design
This is a single, blinded, randomized controlled study It is a prospective comparative analytical study to evaluate the utility of appliance rehabilitation using a combination of upper extremity exoskeleton and continuous passive mobilization in the treatment of AC Figure 1. Study design complies with the SPIRIT guidelines Appendix 1. All eligible patients are informed of the study and its progress. They are invited to participate by the investigator, a physician in the Department of Physical and Rehabilitation Medicine (PRM), Rabat University Hospital, Morocco. If agreeing to participate, the patient will provide and sign an informed consent form Appendix 2.
Setting and location
Patients are recruited from the PRM and Rheumatology sessions at Rabat University Hospital. This study will be conducted at the PRM department at Rabat University Hospital.
Selection criteria
Included participants met the following criteria Table 1.
Inclusion criteria |
Exclusion criteria |
|
|
Table 1 Selection criteria
Intervention
Participants were divided into groups:
Intervention group: Receive:
Sessions were scheduled according to this program:
During the first week, patients received 1 session per day for 5 days, performing only simple movements. Device setup was adjusted according to clinical examination at baseline and gradually increased according to pain threshold.
In the following weeks, the patient will have 3 sessions per week. Composite exercise is started.
Physiotherapist records ROM achieved at the end of each session.
The Armeo® Spring is an ergonomic, adjustable upper limb exoskeleton that combines robotic assistance and virtual reality. It has seven axes, allowing for virtual play in a vast three-dimensional (3D) workspace. It features both arm weights and forearm braces. The gravity compensation system can be adjusted in 9 settings for arms and forearms. This robotic rehabilitation device is connected to software and provides voluntary virtual exercises with visual and auditory feedback. The patient receives 3 sessions per week of 40 minutes each. Each session includes 4 games combining 2D and 3D movements. Functional work is first performed in assisted active mode with maximum lightening, then the workspace is gradually increased and the support system is reduced. A standardized training program have been stablished (Table 2, Appendix 3).
Week |
Session(40min) |
Program |
1 |
1 |
High Flyer, Rain Mug, Brick Breaker, Supermarket |
2 |
High Flyer, Brick Breaker, Balloons, Roll the Ball |
|
3 |
High Flyer, Pirates, Balloons, Cleaning |
|
2 |
1 |
Roll the Ball, Balloons, Save the Monster, Farmer |
2 |
Roll the Ball, Balloons, Pirates, Cleaning |
|
3 |
Roll the Ball, Fishing, Cleaning, Supermarket |
|
3 |
1 |
Balloons, Roll the Ball, Diving, Cleaning |
2 |
Balloons, Fishing, Diving, Farmer |
|
3 |
Balloons, Fishing, Diving, Supermarket |
|
4 |
1 |
Farmer, Fishing, Cleaning, Supermarket |
2 |
Farmer, Fishing, Diving, Supermarket |
|
3 |
Farmer, Fishing, Diving, Supermarket |
Table 2 Armeo training program
Control group
Undergo conventional rehabilitation 24 times. Prescriptions include pain-relieving physiotherapy, passive mobilization, active functional work, and self-programmed learning with a physiotherapist.
Participant safety, failure and withdrawal
Adjuvant treatments allowed during the study were analgesics, anti-inflammatory drugs, corticosteroid infiltration, or topical treatments. Participants may contact the principal investigator with questions or adverse events at any time. In case of pain or injury, they refer to the PRM department where they will be examined by an investigator. The study is considered failed if there is no improvement or worsening after 6 weeks of rehabilitation. The patient will be discontinued from the study and offered another alternative therapy. All participants may withdraw from the study at any time without giving a reason.
Outcomes
Primary outcome
The primary outcome is the Shoulder Pain and Disability Index (SPADI). This is a self-written questionnaire. It consists of two subscales. The first assesses the importance of pain felt on five items. Pain scores range from 0 to 50. The second evaluates the difficulty of activities of daily living based on eight questions. Impairment scores range from 0 to 80. Final scores range from 0 to 130, with higher scores indicating greater pain and disability.
We used the validated Tunisian version (9) Appendix 5.
Secondary outcomes:
Sample size
The target sample size was calculated in collaboration with a team from the Institute of Biostatistics and Clinical Epidemiology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco. The hypothesis is an 18-point improvement in SPADI in the intervention group compared with the control group, with an alpha risk of 0.05, a beta power of 0.8, and a dropout rate of 10%, 16 patients per group must be included.
Randomization
Patients are randomly assigned to one of two groups. The Computer-generated list was handed over by the Institute of Statistics, Faculty of Medicine and Pharmacy, Rabat. A randomization list is given to a member of the team who does not know the participant; The randomization is based on the number assigned to each subject.
Data management
All data will be recorded in a notebook by the principal investigator. Each participant will have their own paper exercise book, which will be kept safe by the lead researcher. Data are transcribed progressively and updated regularly in Excel spreadsheets in digital form to keep a copy of the non-nominated data and to prepare static analysis.
Statistical analysis
Statistical analysis is performed using JAMOVI software. Descriptive statistics are used to examine demographic information such as gender, age, laterality, affected shoulders and concomitant diseases (diabetes). Qualitative variables are expressed as numbers and percentages, quantitative variables are expressed as means and standard deviations for normal distributions, and medians and quartiles for worst cases. Students' T-tests are performed to compare two independent groups based on the alternative hypothesis of superiority of robotic rehabilitation compared to standard care in patients with AC. A repeated measures ANOVA is used to examine changes in scores over time at follow-up in both the intervention and control groups.
AC is defined by pain and a gradual decrease in active and passive ROM associated with contraction of the inflammatory capsule.10 Therefore, patients fear aggressive movements and mobilizations by physical therapists, especially if they are suddenly stretched. As a result, they cause inhibition of mechanical motion.11 Therefore, it makes sense to rely on continuous passive movement. A motorized device gently moves the shoulder joint in three planes during the session. On the one hand, it helps reduce kinesiophobia and gives patients confidence in respecting pain thresholds. On the other hand, it allows progressive tension and thus stretching of the capsule, allowing the improvement of ROM.
Patient-experienced shoulder pain limits use of the affected limb through cortical reorganization and body schema disruption.12 Somatosensory memory is also affected and overly focused on pain.13 This can be exacerbated by comorbidities such as sleep disorders, depressive disorders, and anxiety disorders.14 Armeo® Spring exercises can relieve shoulder pain in patients. By focusing on games with audiovisual feedback, the patient's attention is no longer on their shoulders, but on an enjoyable rehabilitation session.15 Patients are therefore more active and more actively involved in rehabilitation programs. This ergonomic upper limb exoskeleton, with its gravity-assisted system, can help in mechanical movement, reducing patient discomfort.16 This allows patients to progress painlessly and gradually through exercise to increase ROM.
Armeo® Spring, Hocoma, is a medically certified robotic rehabilitation device originally used in the field of neurorehabilitation. It is based on the principle of motor learning. The above cortical reorganizations involve motor learning in addition to body schema modifications. Training is based on repetitive, task-oriented exercises in a virtual environment that help improve limb function.17 Robotic training is a new modality that offers the potential for more effective functional training and repetition.18 To our knowledge, a rehabilitation protocol for AC with exoskeleton that combines passive and active mobilization has not yet been developed. The purpose of this randomized controlled trial was to compare robot training with standard care in patients with AC.
Limitations
Trial status
Patient enrollment began in March 2021, and at the time of submission of this study protocol, the study is ongoing and is recruiting patients. To date, 26 patients have participated in the study. Final results will be published regardless of whether the results are positive, negative or inconclusive.
Ethical approval and consent to participation
The clinical study was approved by the Biomedical Research Ethics Committee of the Rabat Faculty of Medicine and Pharmacy Appendix 7. This approval is based on the Declaration of Helsinki and the guidelines of the International Council on Medical Ethics for Biomedical Research Involving Humans. In the event of significant protocol changes or adverse events, the Principal Investigator will notify the Ethics Committee. Informed consent to participate is obtained from patients prior to enrollment in the study. Only the principal investigator holds personal information about registered participants.
Consent to publication
Informed consent was taken from participants to share their image in submission.
Data availability statement
An Excel spreadsheet containing demographic information and follow-up of patients enrolled to date is available. Corresponding author may be contacted for access or information.
Team Members declare no conflict of interest.
This study received no funding from any investment agency.
Lftah Youssef and Sohaib Reda Physiotherapists at PRM Department, Rabat University Hospital, help in preparing the booklet. He consents to publication Appendix 8.
Dr. Belahcen Amina, at the Institute of Biostatistics and Clinical Epidemiology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Author Dr. Mohamed Guermazi approved the use of the validated Tunisian version of SPADI.
Author’s contribution
Both authors were involved in the methodological development of the study protocol. The authors declare that they have written and reviewed the manuscript. They also consent to publication.
©2023 Skalli, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.